var data={"name":"Treatment issues rheumatology","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Alkylating agents","type":"SUBSECTION","items":[{"name":"General principles of the use of cyclophosphamide in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=general-principles-of-the-use-of-cyclophosphamide-in-rheumatic-diseases"},{"name":"General toxicity of cyclophosphamide in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=general-toxicity-of-cyclophosphamide-in-rheumatic-diseases"}]},{"name":"Biologic response modifying therapies","type":"SUBSECTION","items":[{"name":"Overview of biologic agents and kinase inhibitors in the rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-biologic-agents-and-kinase-inhibitors-in-the-rheumatic-diseases"},{"name":"Role of cytokines in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=role-of-cytokines-in-rheumatic-diseases"},{"name":"Tumor necrosis factor-alpha inhibitors: An overview of adverse effects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=tumor-necrosis-factor-alpha-inhibitors-an-overview-of-adverse-effects"},{"name":"Tumor necrosis factor-alpha inhibitors: Induction of antibodies, autoantibodies, and autoimmune diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=tumor-necrosis-factor-alpha-inhibitors-induction-of-antibodies-autoantibodies-and-autoimmune-diseases"},{"name":"Tumor necrosis factor-alpha inhibitors: Risk of malignancy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=tumor-necrosis-factor-alpha-inhibitors-risk-of-malignancy"}]},{"name":"Complementary and alternative therapy","type":"SUBSECTION","items":[{"name":"Complementary and alternative remedies for rheumatic disorders","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=complementary-and-alternative-remedies-for-rheumatic-disorders"}]},{"name":"Disease modifying antirheumatic drugs","type":"SUBSECTION","items":[{"name":"Antimalarial drugs in the treatment of rheumatic disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antimalarial-drugs-in-the-treatment-of-rheumatic-disease"},{"name":"Cytokine networks in rheumatic diseases: Implications for therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cytokine-networks-in-rheumatic-diseases-implications-for-therapy"}]},{"name":"Glucocorticoids","type":"SUBSECTION","items":[{"name":"Determinants of glucocorticoid dosing","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=determinants-of-glucocorticoid-dosing"},{"name":"Glucocorticoid effects on the immune system","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=glucocorticoid-effects-on-the-immune-system"},{"name":"Glucocorticoid withdrawal","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=glucocorticoid-withdrawal"},{"name":"Intraarticular and soft tissue injections: What agent(s) to inject and how frequently?","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=intraarticular-and-soft-tissue-injections-what-agents-to-inject-and-how-frequently"},{"name":"Major side effects of systemic glucocorticoids","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=major-side-effects-of-systemic-glucocorticoids"}]},{"name":"Immunosuppressive agents","type":"SUBSECTION","items":[{"name":"Effects of antiinflammatory and immunosuppressive drugs on gonadal function and teratogenicity in men with rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=effects-of-antiinflammatory-and-immunosuppressive-drugs-on-gonadal-function-and-teratogenicity-in-men-with-rheumatic-diseases"},{"name":"General principles of the use of cyclophosphamide in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=general-principles-of-the-use-of-cyclophosphamide-in-rheumatic-diseases"},{"name":"General toxicity of cyclophosphamide in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=general-toxicity-of-cyclophosphamide-in-rheumatic-diseases"},{"name":"Mycophenolate: Overview of use and adverse effects in the treatment of rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=mycophenolate-overview-of-use-and-adverse-effects-in-the-treatment-of-rheumatic-diseases"},{"name":"Overview of immunosuppressive and conventional (non-biologic) disease-modifying drugs in the rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-immunosuppressive-and-conventional-non-biologic-disease-modifying-drugs-in-the-rheumatic-diseases"},{"name":"Pharmacology and side effects of azathioprine when used in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacology-and-side-effects-of-azathioprine-when-used-in-rheumatic-diseases"},{"name":"Pharmacology of cyclosporine and tacrolimus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacology-of-cyclosporine-and-tacrolimus"},{"name":"Safety of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=safety-of-antiinflammatory-and-immunosuppressive-drugs-in-rheumatic-diseases-during-pregnancy-and-lactation"}]},{"name":"Joint and soft tissue injections","type":"SUBSECTION","items":[{"name":"Joint aspiration or injection in adults: Complications","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=joint-aspiration-or-injection-in-adults-complications"},{"name":"Joint aspiration or injection in adults: Technique and indications","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=joint-aspiration-or-injection-in-adults-technique-and-indications"},{"name":"Joint aspiration: The dry tap","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=joint-aspiration-the-dry-tap"},{"name":"Musculoskeletal ultrasonography: Guided injection and aspiration of joints and related structures","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=musculoskeletal-ultrasonography-guided-injection-and-aspiration-of-joints-and-related-structures"}]},{"name":"Joint replacement surgery","type":"SUBSECTION","items":[{"name":"Complications of total hip arthroplasty","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=complications-of-total-hip-arthroplasty"},{"name":"Complications of total knee arthroplasty","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=complications-of-total-knee-arthroplasty"},{"name":"Total hip arthroplasty","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=total-hip-arthroplasty"},{"name":"Total knee arthroplasty","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=total-knee-arthroplasty"}]},{"name":"Nonpharmacologic approaches","type":"SUBSECTION","items":[{"name":"Synovectomy for inflammatory arthritis of the knee","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=synovectomy-for-inflammatory-arthritis-of-the-knee"}]},{"name":"Nonsteroidal antiinflammatory drugs","type":"SUBSECTION","items":[{"name":"Aspirin: Mechanism of action, major toxicities, and use in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=aspirin-mechanism-of-action-major-toxicities-and-use-in-rheumatic-diseases"},{"name":"COX-2 selective inhibitors: Adverse cardiovascular effects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cox-2-selective-inhibitors-adverse-cardiovascular-effects"},{"name":"NSAIDs: Pharmacology and mechanism of action","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=nsaids-pharmacology-and-mechanism-of-action"},{"name":"NSAIDs: Therapeutic use and variability of response in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=nsaids-therapeutic-use-and-variability-of-response-in-adults"},{"name":"Nonselective NSAIDs: Adverse cardiovascular effects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=nonselective-nsaids-adverse-cardiovascular-effects"},{"name":"Nonselective NSAIDs: Overview of adverse effects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=nonselective-nsaids-overview-of-adverse-effects"},{"name":"Overview of selective COX-2 inhibitors","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-selective-cox-2-inhibitors"}]},{"name":"Pregnancy","type":"SUBSECTION","items":[{"name":"Safety of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=safety-of-antiinflammatory-and-immunosuppressive-drugs-in-rheumatic-diseases-during-pregnancy-and-lactation"}]},{"name":"Psychosocial factors","type":"SUBSECTION","items":[{"name":"Psychosocial factors and rheumatic disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=psychosocial-factors-and-rheumatic-disease"}]}]}